S-1 IMRT Versus S-1 and Cisplatin Concurrent IMRT in Inoperable Esophageal Squamous Cell Carcinoma

NCT02913066 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

OTHER: S-1 concurrent radiotherapy
OTHER: S-1 plus Cisplatin concurrent radiotherapy

Sponsor

Mianyang Central Hospital